If you are not happy with the below results, you may try another search.
We have found some results with the word you searched.
► Recent advances in immunotherapy open the door to new approaches in cancer treatments. ► Patient variability is a major issue impairing a massive adoption of cell-based immunotherapy. ► Researchers at the Josep Carreras Leukaemia Research Institute have summarized all the previous knowledge on immunotherapy to make it easier for clinicians to dive into it. […]
¡Ya tenemos disponible la Memoria del Registro de Donantes de Médula Ósea (REDMO) de 2021! Esta memoria refleja la labor realizada por los centros de donantes, los centros de colecta, los centros de trasplante, las coordinaciones autonómicas, la Organización Nacional de Trasplantes (ONT) y el REDMO. A lo largo de estos 30 años, el REDMO […]
A previously unnoticed population of pre-leukemic cells might be responsible for some relapses in B-cell acute lymphoblastic leukemia (B-ALL), according to a new research paper published by a team led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institute, in close collaboration with Oxford University and clinicians from Sant Joan de […]
Scientists have long queried the causes of immune disorders in only one of two identical twins with identical genes. New research from the Wellcome Sanger Institute, the Josep Carreras Leukaemia Research Institute in Spain and their collaborators, has found the answer lies in both alterations in immune cell-cell communication and the epigenome, the host of […]
“Ya no se puede hacer nada”. En infinidad de ocasiones hemos escuchado esta frase en películas. Está grabada en nuestro aprendizaje social que, cuando no se puede curar a un paciente, “ya no se puede hacer nada”. Aunque puede costar de entender, es una falacia. Aun no pudiendo asegurar la curación de una persona, se […]
I want to receive the latest news
(+34) 93 414 55 66
Contact
Espacio socios y amigos
